This is a single-center, pilot, PET-imaging study of the novel radiotracer 89Zirconium-89 DFO conjugated to the YS5 monoclonal antibody (\[89Zr\]DFO-YS5) in pa…

Bladder CancerNerve Sheath TumorNerve Sheath Tumors+9 more

~Estimated

~$10 – $7,500

Robert Flavell, MD, PhDNCT07664397

Surveillance for Malignant Transformation of Neurofibromatosis Type 1 (NF1) Related Peripheral Nerve Sheath Tumors (PNST)

Background: Neurofibromatosis type 1 (NF1) is a genetic disease that can cause many symptoms. About half of people with NF1 will develop benign (noncancerous)…

Neurofibromatosis 1Nerve Sheath Neoplasms

~Estimated

~$10 – $675

National Cancer Institute (NCI)NCT06222203

Observational

HiPPI: A Phase 2 Trial of Hypofractionated Pencil Beam Scanning Proton Therapy for Benign Intracranial Tumors

This phase II trial studies how well hypofractionated proton or photon radiation therapy works in treating patients with brain tumors. Hypofractionated radiati…

Grade I MeningiomaGrade II MeningiomaGrade III Meningioma+4 more

~Estimated

~$10 – $6,250

Emory UniversityNCT04278118